{"id":"W2793477810","doi":"10.1016/j.ahj.2018.01.011","title":"Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)","year":2018,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"National Heart, Lung, and Blood Institute; Pharmaceuticals Bayer; National Institutes of Health; Bayer Fund; Merck; Janssen Pharmaceuticals; Bayer; AstraZeneca","keywords":"Medicine; Rivaroxaban; Revascularization; Myocardial infarction; Clopidogrel; Aspirin; Surgery; Randomized controlled trial; Clinical endpoint; Stroke (engine); Critical limb ischemia; Coronary artery disease; Internal medicine; Cardiology; Population; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007590103,0.0001952166,0.000507604,0.0001220013,0.0002452523,0.00006539211,0.0001208215,0.00001919477,0.00006014494],"category_scores_gemma":[0.0003286159,0.0001100685,0.000224001,0.0002346452,0.0002684929,0.0001565866,0.000041736,0.0001154227,8.290916e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006972321,"about_ca_system_score_gemma":0.0001540822,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003762983,"about_ca_topic_score_gemma":0.00005932813,"domain_scores_codex":[0.9982718,0.0002398788,0.0004269753,0.0002929402,0.0004810194,0.0002873999],"domain_scores_gemma":[0.998561,0.000358968,0.0001796058,0.0003948009,0.0002822991,0.0002233374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005810808,0.001622281,0.9842147,0.00008781641,0.001229237,0.00008905887,0.0009362933,0.0007967945,0.00006474346,0.00001958359,0.001166185,0.003962549],"study_design_scores_gemma":[0.008474212,0.004849671,0.9747151,0.00006483898,0.0006986471,0.0000660505,0.001039619,0.006187737,0.00001041265,0.00004690432,0.003680512,0.0001663563],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9622583,0.0001703342,0.03089961,0.002786308,0.00006916247,0.003788786,0.000008678299,0.0000151546,0.000003624645],"genre_scores_gemma":[0.9905474,0.00005617063,0.00784188,0.0007034889,0.0003092541,0.0004106487,0.00001239559,0.00003452539,0.00008429624],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.028289,"threshold_uncertainty_score":0.4488464,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0359267663805228,"score_gpt":0.3056857976363951,"score_spread":0.2697590312558724,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}